58 results on '"Warren, Robin M."'
Search Results
2. Identification and molecular characterization of Mycobacterium bovis DNA in GeneXpert® MTB/RIF ultra-positive, culture-negative sputum from a rural community in South Africa
3. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study
4. Whole genome sequencing improves the discrimination between Mycobacterium bovis strains on the southern border of Kruger National Park, South Africa
5. Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
6. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
7. Optimizing liquefaction and decontamination of sputum for DNA extraction from Mycobacterium tuberculosis
8. Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
9. Drug resistant tuberculosis cases from the Copperbelt province and Northern regions of Zambia: Genetic diversity, demographic and clinical characteristics
10. A multi-phenotype genome-wide association study of clades causing tuberculosis in a Ghanaian- and South African cohort
11. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
12. Development of a cytokine gene expression assay for the relative quantification of the African elephant (Loxodonta africana) cell-mediated immune responses
13. Optimisation of the tuberculin skin test for detection of Mycobacterium bovis in African buffaloes (Syncerus caffer)
14. Cytokine biomarker discovery in the white rhinoceros (Ceratotherium simum)
15. Optimized interferon-gamma release assays for detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
16. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
17. Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting
18. Impact of Mycobacterium bovis-induced pathology on interpretation of QuantiFERON®-TB Gold assay results in African buffaloes (Syncerus caffer)
19. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda
20. Evolution of rifampicin treatment for tuberculosis
21. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
22. Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
23. Transmission of drug-resistant tuberculosis in HIV-endemic settings
24. IP-10: A potential biomarker for detection of Mycobacterium bovis infection in warthogs (Phacochoerus africanus)
25. Mycobacterial nucleoid associated proteins: An added dimension in gene regulation
26. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
27. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
28. Association of toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms
29. Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in Tanzania
30. The impact of genotype on the phenotype of Mycobacterium tuberculosis ΔsufR mutants
31. Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape
32. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa
33. Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotype
34. Proteogenomic Analysis of Polymorphisms and Gene Annotation Divergences in Prokaryotes using a Clustered Mass Spectrometry-Friendly Database
35. Using a Label-free Proteomics Method to Identify Differentially Abundant Proteins in Closely Related Hypo- and Hypervirulent Clinical Mycobacterium tuberculosis Beijing Isolates
36. Extensively Drug-resistant Tuberculosis: Epidemiology and Management Challenges
37. Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
38. Use of the MILLIPLEX® bovine cytokine/chemokine multiplex assay to identify Mycobacterium bovis-infection biomarkers in African buffaloes (Syncerus caffer)
39. Multiple, independent, identical IS 6110 insertions in Mycobacterium tuberculosis PPE genes
40. Pulmonary infection due to the dassie bacillus ( Mycobacterium tuberculosis complex sp.) in a free-living dassie (rock hyrax— Procavia capensis) from South Africa
41. Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon
42. The role of IS 6110 in the evolution of Mycobacterium tuberculosis
43. Parallel measurement of IFN-γ and IP-10 in QuantiFERON®-TB Gold (QFT) plasma improves the detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
44. Proportion of tuberculosis transmission that takes place in households in a high-incidence area
45. Parallel testing increases detection of Mycobacterium bovis-infected African buffaloes (Syncerus caffer)
46. Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance
47. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis
48. The stability of plasma IP-10 enhances its utility for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
49. MDR tuberculosis control: time to change the dogma?
50. The evaluation of candidate biomarkers of cell-mediated immunity for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.